Progressive Supranuclear Palsy
📧 Sign up to get email alerts when something new happens for Progressive Supranuclear Palsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy [Phase 2]
Phase 2 clinical trial update on safety and efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy.
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP) [NA]
Clinical trial update on the effects of Coenzyme Q10 in progressive supranuclear palsy has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Effects of Coenzyme Q10 in PSP and CBD [Phase 2, Phase 3]
Clinical trial update notes completion of Phase 2/Phase 3 studies evaluating coenzyme Q10 for Progressive Supranuclear Palsy and corticobasa…
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Neuropsychological Evaluation for Early Diagnosis of PSP
This update reports the completion of a clinical trial evaluating neuropsychological evaluation methods for early diagnosis of Progressive S…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
This entry notes the completion of a clinical trial evaluating transcranial duplex scanning and SPECT imaging in Parkinsonian syndromes cond…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-11-07Clinical Trial Update: Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy
This clinical trial update describes a study using chromatic pupillometry to assess the melanopsin-light pathway in Progressive Supranuclear…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy [Phase 1]
A Phase 1 trial assessing safety, tolerability, and pharmacokinetics of C2N-8E12 in progressive supranuclear palsy has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for alpha-lipoic acid combined with Acetyl-L-carnitine in progressive supranuclear pals…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Risk Factors for Progressive Supranuclear Palsy (PSP)
The document notes the completion of a clinical trial evaluating risk factors for Progressive Supranuclear Palsy (PSP).
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy. [NA]
This document provides an update on a pilot clinical trial evaluating a combination of pyruvate, creatine, and niacinamide for progressive s…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes [NA]
A clinical trial evaluating magnetic resonance imaging in the diagnosis of Parkinsonian syndromes has been terminated.
-
CLINICAL_TRIALS research · 2016-12-16Clinical Trial Update: Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects [Phase 1]
Phase 1 study evaluating the PET tracer [18F]MNI-777 as a marker of tau pathology in tauopathy subjects and healthy controls has been comple…
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies [EARLY_Phase 1]
Early Phase 1 study evaluating the PET radioligand [18F]MNI-815 for imaging tau in tauopathies has been completed, involving Alzheimer's dis…
-
CLINICAL_TRIALS research · 2016-12-06Clinical Trial Update: Rehabilitation in Patients With Progressive Supranuclear Palsy [NA]
A clinical trial evaluating rehabilitation in Progressive Supranuclear Palsy has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: 2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism [EARLY_Phase 1]
A Phase 1 PET tracer trial for tauopathy in unclassified parkinsonism (progressive supranuclear palsy and multi-system atrophy) has complete…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls
The update presents results from a cerebrospinal fluid biomarker study in participants with Alzheimer's disease, progressive supranuclear pa…
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
This clinical trial update notes that a study evaluating repetitive transcranial magnetic stimulation (TMS) for progressive supranuclear pal…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Analysis of the Enteric Nervous System Using Colonic Biopsies [NA]
A completed clinical trial analyzed the enteric nervous system using colonic biopsies in Parkinson's disease, multiple system atrophy, and p…
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy [Phase 3]
Phase 3 study evaluating the efficacy, tolerability, and safety of Azilect (rasagiline) in progressive supranuclear palsy has been terminate…
-
CLINICAL_TRIALS research · 2013-04-04Clinical Trial Update: Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism [Phase 1, Phase 2]
This entry reports a clinical trial evaluating bone marrow stem cell therapy for Progressive Supranuclear Palsy (PSP), a rare parkinsonian s…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy [Phase 2, Phase 3]
Clinical trial update states that the study of Davunetide for Progressive Supranuclear Palsy has completed Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2012-11-05Clinical Trial Update: Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine) [Phase 2]
A Phase 2 clinical trial evaluating valproic acid (Depakine) in progressive supranuclear palsy has completed.
-
CLINICAL_TRIALS research · 2012-09-27Clinical Trial Update: Research of Biomarkers in Parkinson Disease
A completed clinical trial evaluating biomarkers in Parkinson disease and related parkinsonian conditions.
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy [NA]
A completed trial evaluating two oral doses of NP031112 versus placebo in mild-to-moderate Progressive Supranuclear Palsy. The study assesse…
-
FDA approval · 2011-01-14FDA Approved: DATSCAN — Original Application (Medi-Physics Inc. dba GE Healthcare.)
FDA approved the original application for DATSCAN (ioflupane I-123), a radiopharmaceutical for brain imaging to aid in differentiating Parki…